Clinical Trials Browser

Phase 1 × INDUSTRY × Prostate Cancer Metastatic × Clear all

NCT03575819 2024-02-01

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 1 Completed

Prostate Cancer Metastatic